These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4025007)

  • 1. Abnormal renal sodium excretion in the nephrotic syndrome after furosemide: relation to glomerular filtration rate.
    Danielsen H; Pedersen EB; Madsen M; Jensen T
    Acta Med Scand; 1985; 217(5):513-8. PubMed ID: 4025007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective renal water excretion in nephrotic syndrome: the relationship between renal water excretion and kidney function, arginine vasopressin, angiotensin II and aldosterone in plasma before and after oral water loading.
    Pedersen EB; Danielsen H; Madsen M; Jensen T
    Eur J Clin Invest; 1985 Feb; 15(1):24-9. PubMed ID: 3921381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal water excretion before and after remission of nephrotic syndrome: relationship between free water clearance and kidney function, arginine vasopressin, angiotensin II and aldosterone in plasma before and after oral water loading.
    Pedersen EB; Danielsen H; Sørensen SS; Jespersen B
    Clin Sci (Lond); 1986 Jul; 71(1):97-104. PubMed ID: 3709077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of frusemide on atrial natriuretic peptide, guanosine cyclic monophosphate, angiotensin II, aldosterone, vasopressin, prostaglandin E2 and blood volume in the nephrotic syndrome.
    Jespersen B; Sørensen SS; Pedersen EB
    Nephrol Dial Transplant; 1991; 6(6):402-9. PubMed ID: 1652115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal vasopressin and aldosterone response to furosemide in essential hypertension.
    Pedersen EB; Danielsen H; Madsen M; Sørensen SS; Thomsen OO
    Acta Med Scand; 1986; 219(4):387-92. PubMed ID: 3716880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exaggerated natriuresis in adult polycystic kidney disease.
    Danielsen H; Nielsen AH; Pedersen EB; Herlevsen P; Kornerup HJ; Posborg V
    Acta Med Scand; 1986; 219(1):59-66. PubMed ID: 3953317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of glomerular filtration rate in the impaired sodium and water excretion of patients with the nephrotic syndrome.
    Shapiro MD; Nicholls KM; Groves BM; Schrier RW
    Am J Kidney Dis; 1986 Aug; 8(2):81-7. PubMed ID: 3526875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of posture on sodium excretion and diuretic efficacy in nephrotic patients.
    Minutolo R; Andreucci M; Balletta MM; Russo D
    Am J Kidney Dis; 2000 Oct; 36(4):719-27. PubMed ID: 11007673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased urinary aquaporin-2 excretion in response to furosemide in patients with chronic heart failure.
    Starklint J; Bech JN; Nyvad O; Jensen P; Pedersen EB
    Scand J Clin Lab Invest; 2006; 66(1):55-66. PubMed ID: 16464787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial natriuretic factor, angiotensin II, aldosterone, arginine vasopressin and urinary prostaglandin E2 excretion in hyperfiltrating unilaterally nephrectomized humans.
    Sørensen SS; Jespersen B; Pedersen EB
    Scand J Clin Lab Invest; 1990 Jun; 50(4):371-8. PubMed ID: 2144053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II, aldosterone and arginine vasopressin in plasma in congestive heart failure.
    Pedersen EB; Danielsen H; Jensen T; Madsen M; Sørensen SS; Thomsen OO
    Eur J Clin Invest; 1986 Feb; 16(1):56-60. PubMed ID: 3084274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 3% saline and furosemide on biomarkers of kidney injury and renal tubular function and GFR in healthy subjects - a randomized controlled trial.
    Mose FH; Jörgensen AN; Vrist MH; Ekelöf NP; Pedersen EB; Bech JN
    BMC Nephrol; 2019 Jun; 20(1):200. PubMed ID: 31159750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced natriuretic effect of atrial natriuretic peptide in nephrotic syndrome: a possible role of decreased cyclic guanosine monophosphate.
    Jespersen B; Eiskjaer H; Mogensen CE; Sørensen SS; Pedersen EB
    Nephron; 1995; 71(1):44-53. PubMed ID: 8538848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of extracellular volume in early polycystic kidney disease.
    Danielsen H; Pedersen EB; Nielsen AH; Herlevsen P; Kornerup HJ; Posborg V
    Acta Med Scand; 1986; 219(4):399-405. PubMed ID: 3716882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary excretion of aquaporin-2 after furosemide and felodipine in healthy humans.
    Starklint J; Bech JN; Pedersen EB
    Scand J Clin Lab Invest; 2005; 65(3):249-61. PubMed ID: 16095054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased atrial natriuretic peptide in an early stage of chronic glomerulonephritis.
    Sørensen SS; Danielsen H; Pedersen EB
    Scand J Clin Lab Invest; 1988 Jun; 48(4):347-55. PubMed ID: 2976977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-renal-transplant hypertension. Urine volume, free water clearance and plasma concentrations of arginine vasopressin, angiotensin II and aldosterone before and after oral water loading in hypertensive and normotensive renal transplant recipients.
    Pedersen EB; Danielsen H; Knudsen F; Nielsen AH; Jensen T; Kornerup HJ; Madsen M
    Scand J Clin Lab Invest; 1986 Sep; 46(5):451-8. PubMed ID: 3529350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary excretion of endogenous ouabain-like substance in furosemide-treated neonates: its relation to renal excretory pattern and endocrine factors.
    Sulyok E; Adamovits K; Worgall S; Rascher W
    Biol Neonate; 1997; 72(6):352-62. PubMed ID: 9428995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial.
    Matthesen SK; Larsen T; Vase H; Lauridsen TG; Jensen JM; Pedersen EB
    Clin Exp Hypertens; 2013; 35(5):313-24. PubMed ID: 22966789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.